Cargando…
Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge
Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse model of acute lung injury. At 3 h post-lipopolysaccha...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928308/ https://www.ncbi.nlm.nih.gov/pubmed/24558433 http://dx.doi.org/10.1371/journal.pone.0088814 |
_version_ | 1782304239511404544 |
---|---|
author | Huang, Xiaojia Sun, Kai Zhao, Yidan D. Vogel, Stephen M. Song, Yuanling Mahmud, Nadim Zhao, You-Yang |
author_facet | Huang, Xiaojia Sun, Kai Zhao, Yidan D. Vogel, Stephen M. Song, Yuanling Mahmud, Nadim Zhao, You-Yang |
author_sort | Huang, Xiaojia |
collection | PubMed |
description | Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse model of acute lung injury. At 3 h post-lipopolysaccharide (LPS) challenge, fCB-CD34(+) cells were transplanted i.v. to mice while CD34(−) cells or PBS were administered as controls in separate cohorts of mice. We observed that fCB-CD34(+) cell treatment inhibited lung vascular injury evident by decreased lung vascular permeability. In contrast, CD34(−) cells had no effects on lung vascular injury. Lung inflammation determined by myeloperoxidase activity, neutrophil sequestration and expression of pro-inflammatory mediators was attenuated in fCB-CD34(+) cell-treated mice at 26 h post-LPS challenge compared to PBS or CD34(−) cell-treated controls. Importantly, lung inflammation in fCB-CD34(+) cell-treated mice was returned to normal levels as seen in basal mice at 52 h post-LPS challenge whereas PBS or CD34(−) cell-treated control mice exhibited persistent lung inflammation. Accordingly, fCB-CD34(+) cell-treated mice exhibited a marked increase of survival rate. Employing in vivo 5-bromo-2′-deoxyuridine incorporation assay, we found a drastic induction of lung endothelial proliferation in fCB-CD34(+) cell-treated mice at 52 h post-LPS compared to PBS or CD34(−) cell-treated controls, which contributed to restoration of vascular integrity and thereby inhibition of lung inflammation. Taken together, these data have demonstrated the protective effects of fCB-CD34(+) cell on acute lung injury induced by LPS challenge, suggesting fCB-CD34(+) cells are an important source of stem cells for the treatment of acute lung injury. |
format | Online Article Text |
id | pubmed-3928308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39283082014-02-20 Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge Huang, Xiaojia Sun, Kai Zhao, Yidan D. Vogel, Stephen M. Song, Yuanling Mahmud, Nadim Zhao, You-Yang PLoS One Research Article Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse model of acute lung injury. At 3 h post-lipopolysaccharide (LPS) challenge, fCB-CD34(+) cells were transplanted i.v. to mice while CD34(−) cells or PBS were administered as controls in separate cohorts of mice. We observed that fCB-CD34(+) cell treatment inhibited lung vascular injury evident by decreased lung vascular permeability. In contrast, CD34(−) cells had no effects on lung vascular injury. Lung inflammation determined by myeloperoxidase activity, neutrophil sequestration and expression of pro-inflammatory mediators was attenuated in fCB-CD34(+) cell-treated mice at 26 h post-LPS challenge compared to PBS or CD34(−) cell-treated controls. Importantly, lung inflammation in fCB-CD34(+) cell-treated mice was returned to normal levels as seen in basal mice at 52 h post-LPS challenge whereas PBS or CD34(−) cell-treated control mice exhibited persistent lung inflammation. Accordingly, fCB-CD34(+) cell-treated mice exhibited a marked increase of survival rate. Employing in vivo 5-bromo-2′-deoxyuridine incorporation assay, we found a drastic induction of lung endothelial proliferation in fCB-CD34(+) cell-treated mice at 52 h post-LPS compared to PBS or CD34(−) cell-treated controls, which contributed to restoration of vascular integrity and thereby inhibition of lung inflammation. Taken together, these data have demonstrated the protective effects of fCB-CD34(+) cell on acute lung injury induced by LPS challenge, suggesting fCB-CD34(+) cells are an important source of stem cells for the treatment of acute lung injury. Public Library of Science 2014-02-18 /pmc/articles/PMC3928308/ /pubmed/24558433 http://dx.doi.org/10.1371/journal.pone.0088814 Text en © 2014 Huang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Huang, Xiaojia Sun, Kai Zhao, Yidan D. Vogel, Stephen M. Song, Yuanling Mahmud, Nadim Zhao, You-Yang Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title | Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title_full | Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title_fullStr | Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title_full_unstemmed | Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title_short | Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge |
title_sort | human cd34(+) progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following lps challenge |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928308/ https://www.ncbi.nlm.nih.gov/pubmed/24558433 http://dx.doi.org/10.1371/journal.pone.0088814 |
work_keys_str_mv | AT huangxiaojia humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT sunkai humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT zhaoyidand humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT vogelstephenm humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT songyuanling humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT mahmudnadim humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge AT zhaoyouyang humancd34progenitorcellsfreshlyisolatedfromumbilicalcordbloodattenuateinflammatorylunginjuryfollowinglpschallenge |